(Q84976224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

Kirsi Gröndahl-Yli-Hannuksela

13 February 2020

series ordinal

2

object named as

Kirsi Gröndahl-Yli-Hannuksela

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

4

Jussi Mertsola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

6

Qiushui He

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Alex-Mikael Barkoff

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Juho Vuononvirta

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

13 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

6897-6902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Pertussis before and after the introduction of acellular pertussis vaccines in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Acellular pertussis vaccines in Japan: past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Factors contributing to pertussis resurgence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Pertussis disease burden in the household: how to protect young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Pertussis in Older Adults: Prospective Study of Risk Factors and Morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

The epidemiology of pertussis in Germany: past and present

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Porin A-specific antibody avidity in patients who are convalescing from meningococcal B disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Maturation of rubella IgG avidity over time after acute rubella infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Bordetella pertussisProtein Pertactin Induces Type‐Specific Antibodies: One Possible Explanation for the Emergence of Antigenic Variants?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV/Hib.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Gene polymorphism in toll-like receptor 4: effect on antibody production and persistence after acellular pertussis vaccination during adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

DTaP vaccines from north american vaccine (NAVA): composition and critical parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.003

10.1016/J.VACCINE.2012.09.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22981763%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference